Rapamycin
Longevity Lab
It’s time to speed things up!
Rapamycin is one of the most promising longevity compounds ever discovered. It is time to accelerate research on mTOR inhibitors like rapamycin and begin developing combination therapies based on them. Our goal with this approach is to explore the possibilities of pushing the boundaries of human longevity and ending the era of age‑related diseases. This is why we launched this lab, where we collaborate with other labs, researchers, organizations and with you to turn this vision into reality. Join us today and let us work together to create a future where everyone can live a life free from age‑related diseases.
(Plus get this great Rapamycin overview sheet)
Longevity Lab
I get frustrated and disappointed that the research progress around the best and most promising longevity compound Rapamycin is moving way too slow forward. One reason for this is that there is no valid patent for Rapamycin anymore and this makes it hard to capitalize on the substance. My philanthropic personality just can't accept this situation so I will do what I can together with other passionate people to push mTOR inhibitors such as Rapamycin up to the top of the hill. After that I think things will start to accelerate quite fast almost by themselves. So my N=1 experiment around Rapamycin, my posts on social media about mTOR inhibition and the launch of the Rapamycin Longevity Series podcast are my ways to contribute to the field. Now it’s time to take the next step and launch the Rapamycin Longevity Lab and start pushing the snowball forward together with other people and organizations.
Krister Kauppi
Founder of the Rapamycin Longevity Lab
